Earliest Stage Treatment of Aktinic Keratosis With Imiquimod 3.75% Cream

Summary

Earliest Stage Treatment of Actinic Keratosis with Imiquimod 3.75% Cream: The study is to demonstrate that Aktinic Keratosis are present before they are clinically visible, i.e. in a subclinical stage. Since on the basis of the research situation, also subclinical AK can proliferate into the dermis, it is possible that with the application of Imiquimod on chronically light-exposed skin, undetected squamous cell carcinoma can be recognized and treated at the same time.

Timeline

Start

2021-04-16

Primary completion

2021-08-23

Completion

2021-08-23

Drugs

Indications